The Application of Resveratrol Derivatives in Oral Cells Reduces the Oxidative Stress Induced by Glucocorticoids

Oxidative stress and high levels of reactive oxygen species (ROS) are linked to various age-related diseases and chronic conditions, including damage to oral tissues. Dexamethasone (DEX), a widely used glucocorticoid in dentistry, can have side effects like increased ROS production and delayed wound healing. Resveratrol (RSV) is known for its antioxidant properties, but its limited bioavailability hinders its clinical use. This study investigated the potential of two RSV derivatives (1d and 1h) to address these limitations. The antioxidant abilities of 1d and 1h (5 mu M) against DEX-induced oxidative stress (200 mu M) were evaluated in human gingival fibroblasts (hGFs) and osteoblasts (hOBs). The effects of these compounds on cell viability, morphology, ROS levels, SOD activity, gene expression, and collagen production were evaluated. RSV derivatives, under DEX-induced oxidative stress condition, improved cell growth at 72 h (191.70 +/- 10.92% for 1d+DEX and 184.80 +/- 13.87% for 1h+DEX), morphology, and SOD activity (77.33 +/- 3.35 OD for 1d+DEX; 76.87 +/- 3.59 OD for 1h+DEX at 1 h), while reducing ROS levels (2417.33 +/- 345.49 RFU for 1d+DEX and 1843.00 +/- 98.53 RFU at 4 h), especially in hOBs. The co-treatment of RSV or derivatives with DEX restored the expression of genes that were downregulated by DEX, such as HO-1 (1.76 +/- 0.05 for 1d+DEX and 1.79 +/- 0.01 for 1h+DEX), CAT (0.97 +/- 0.06 for 1d+DEX and 0.99 +/- 0.03 for 1h+DEX), NRF2 (1.62 +/- 0.04 for 1d+DEX and 1.91 +/- 0.05 for 1h+DEX), SOD1 (1.63 +/- 0.15 for 1d+DEX and 1.69 +/- 0.04 for 1h+DEX). In addition, 1d and 1h preserved collagen production (111.79 +/- 1.56 for 1d+DEX and 122.27 +/- 1.56 for 1h+DEX). In conclusion, this study suggests that the RSV derivatives 1d and 1h hold promise as potential antioxidant agents to counteract DEX-induced oxidative stress. These findings contribute to the development of novel therapeutic strategies for managing oxidative stress-related oral conditions.